Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2020 Mar 1;155(3):194-204.
doi: 10.1001/jamasurg.2019.5470.

Interventions and Operations 5 Years After Bariatric Surgery in a Cohort From the US National Patient-Centered Clinical Research Network Bariatric Study

Anita Courcoulas  1 , R Yates Coley  2 , Jeanne M Clark  3 , Corrigan L McBride  4 , Elizabeth Cirelli  5 , Kathleen McTigue  6   7 , David Arterburn  2 , Karen J Coleman  8 , Robert Wellman  2 , Jane Anau  2 , Sengwee Toh  9 , Cheri D Janning  10 , Andrea J Cook  2 , Neely Williams  11 , Jessica L Sturtevant  9 , Casie Horgan  9 , Ali Tavakkoli  12 ; PCORnet Bariatric Study Collaborative
Affiliations
Comparative Study

Interventions and Operations 5 Years After Bariatric Surgery in a Cohort From the US National Patient-Centered Clinical Research Network Bariatric Study

Anita Courcoulas et al. JAMA Surg. .

Abstract

Importance: Additional data comparing longer-term problems associated with various bariatric surgical procedures are needed for shared decision-making.

Objective: To compare the risks of intervention, operation, endoscopy, hospitalization, and mortality up to 5 years after 2 bariatric surgical procedures.

Design, setting, and participants: Adults who underwent Roux-en-Y gastric bypass (RYGB) or sleeve gastrectomy (SG) between January 1, 2005, and September 30, 2015, within the National Patient-Centered Clinical Research Network. Data from 33 560 adults at 10 centers within 4 clinical data research networks were included in this cohort study. Information was extracted from electronic health records using a common data model and linked to insurance claims and mortality indices. Analyses were conducted from January 2018 through October 2019.

Exposures: Bariatric surgical procedures.

Main outcomes and measures: The primary outcome was time until operation or intervention. Secondary outcomes included endoscopy, hospitalization, and mortality rates.

Results: Of 33 560 adults, 18 056 (54%) underwent RYGB, and 15 504 (46%) underwent SG. The median (interquartile range) follow-up for operation or intervention was 3.4 (1.6-5.0) years for RYGB and 2.2 (0.9-3.6) years for SG. The overall mean (SD) patient age was 45.0 (11.5) years, and the overall mean (SD) patient body mass index was 49.1 (7.9). The cohort was composed predominantly of women (80%) and white individuals (66%), with 26% of Hispanic ethnicity. Operation or intervention was less likely for SG than for RYGB (hazard ratio, 0.72; 95% CI, 0.65-0.79; P < .001). The estimated, adjusted cumulative incidence rates of operation or intervention at 5 years were 8.94% (95% CI, 8.23%-9.65%) for SG and 12.27% (95% CI, 11.49%-13.05%) for RYGB. Hospitalization was less likely for SG than for RYGB (hazard ratio, 0.82; 95% CI, 0.78-0.87; P < .001), and the 5-year adjusted cumulative incidence rates were 32.79% (95% CI, 31.62%-33.94%) for SG and 38.33% (95% CI, 37.17%-39.46%) for RYGB. Endoscopy was less likely for SG than for RYGB (hazard ratio, 0.47; 95% CI, 0.43-0.52; P < .001), and the adjusted cumulative incidence rates at 5 years were 7.80% (95% CI, 7.15%-8.43%) for SG and 15.83% (95% CI, 14.94%-16.71%) for RYGB. There were no differences in all-cause mortality between SG and RYGB.

Conclusions and relevance: Interventions, operations, and hospitalizations were relatively common after bariatric surgical procedures and were more often associated with RYGB than SG.

Trial registration: ClinicalTrials.gov identifier: NCT02741674.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Courcoulas reported receiving grants from Allurion Technologies outside the submitted work. Dr Arterburn reported receiving grants from the National Institutes of Health and nonfinancial support from IFSO Latin America Chapter outside the submitted work. Dr Coleman reported receiving grants from the National Institutes of Health and from the US Food and Drug Administration outside the submitted work. No other disclosures were reported.

Figures

Figure.
Figure.. Cumulative Incidence Rates of Operation or Intervention, Revision, Endoscopy, and Hospitalization
RYGB indicates Roux-en-Y gastric bypass; SG, sleeve gastrectomy; solid lines, estimated cumulative probabilities; and shading, 95% CIs.
See this image and copyright information in PMC

Comment in

References

    1. Courcoulas AP, Yanovski SZ, Bonds D, et al. . Long-term outcomes of bariatric surgery: a National Institutes of Health symposium. JAMA Surg. 2014;149(12):1323-1329. doi:10.1001/jamasurg.2014.2440 - DOI - PMC - PubMed
    1. Wolfe BM, Belle SH. Long-term risks and benefits of bariatric surgery: a research challenge. JAMA. 2014;312(17):1792-1793. doi:10.1001/jama.2014.12966 - DOI - PubMed
    1. Brethauer SA, Kim J, el Chaar M, et al. . Standardized outcomes reporting in metabolic and bariatric surgery. Surg Obes Relat Dis. 2015;11(3):489-506. doi:10.1016/j.soard.2015.02.003 - DOI - PubMed
    1. Khorgami Z, Andalib A, Aminian A, Kroh MD, Schauer PR, Brethauer SA. Predictors of readmission after laparoscopic gastric bypass and sleeve gastrectomy: a comparative analysis of ACS-NSQIP database. Surg Endosc. 2016;30(6):2342-2350. doi:10.1007/s00464-015-4477-2 - DOI - PubMed
    1. Hutter MM, Schirmer BD, Jones DB, et al. . First report from the American College of Surgeons Bariatric Surgery Center Network: laparoscopic sleeve gastrectomy has morbidity and effectiveness positioned between the band and the bypass. Ann Surg. 2011;254(3):410-420. doi:10.1097/SLA.0b013e31822c9dac - DOI - PMC - PubMed

Publication types

Associated data